KENJI OYASU: Open Payments
NPI 1487768552 · WAUKEGAN, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$527 in 34 payments from 6 companies in 2025. Trend: 2023 $227 · 2024 $379 · 2025 $527
Food & beverage: $527
| Company | Payments | Amount |
|---|---|---|
| Braeburn Inc. | 22 | $239 |
| Janssen Pharmaceuticals, Inc | 7 | $174 |
| Indivior Inc. | 2 | $45 |
| REVANCE THERAPEUTICS, INC. | 1 | $35 |
| Galderma Laboratories, L.P. | 1 | $23 |
| Janssen Scientific Affairs, LLC | 1 | $10 |
Products named: BRIXADI, SPRAVATO, SUBLOCADE, DAXXIFY.
Industry payments across IL — which companies pay providers there.
